Drug profile · INN
nebivolol hydrochloride
NEBIVOLOL HYDROCHLORIDE
nebivolol hydrochloride (NEBIVOLOL HYDROCHLORIDE) is a beta-1 adrenergic receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — nebivolol hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
nebivolol hydrochloride (NEBIVOLOL HYDROCHLORIDE) is a beta-1 adrenergic receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-1 adrenergic receptor antagonist
Primary target: Beta-1 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is nebivolol hydrochloride?
nebivolol hydrochloride (NEBIVOLOL HYDROCHLORIDE) is a beta-1 adrenergic receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for nebivolol hydrochloride?
NEBIVOLOL HYDROCHLORIDE is a marketed brand name for nebivolol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nebivolol hydrochloride?
nebivolol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.